Gapping up
In reaction to earnings/guidance:
- CDLX +22.6%, TWOU +13.7%, DDOG +12.8%, FVRR +9%, GOOS +6.8%, ADT +5.8%, ADPT +5.6%, YY +4.4%, HUYA +4.2%, ENR +3.6%, VRAY +3.2%, OMER +2.9%, MTSI +2.9%, RUN +2.5%, LK +2.2%, HCAT +1.5%, HIIQ +1.4%, SPB +1.4%, KWR +0.8%, MUFG +0.7%
M&A news:
- TECD +3.7% (enters definitive agreement to be acquired by funds managed by affiliates of Apollo Global Management (APO) for $130/share)
- CBPX +1.5% (to be acquired by Saint-Gobain for $37.00 per share)
Other news:
- IO +4.3% (awarded "large" two-year ocean bottom nodal data processing and imaging contract by ARGAS)
- ACRX +2.2% (announces a publication analyzing pooled dosing and efficacy data from use of the sufentanil sublingual tablet (SST) 30 mcg among multiple demographic subgroups)
- AMRN +2.1% (continued strength)
- REAL +1.2% (issues statement to "[set] the record straight on its authentication process")
Analyst comments:
- INFN +0.9% (upgraded to Neutral from Underweight at JP Morgan)